These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11495589)

  • 21. Inhibition of both thioredoxin reductase and glutathione reductase may contribute to the anticancer mechanism of TH-302.
    Li S; Zhang J; Li J; Chen D; Matteucci M; Curd J; Duan JX
    Biol Trace Elem Res; 2010 Sep; 136(3):294-301. PubMed ID: 19838642
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and in vitro antitumor activity of oligonucleotide-tethered and related platinum complexes.
    Cai L; Lim K; Ren S; Cadena RS; Beck WT
    J Med Chem; 2001 Aug; 44(18):2959-65. PubMed ID: 11520204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thioredoxin reductase inhibition by antitumor quinols: a quinol pharmacophore effect correlating to antiproliferative activity.
    Chew EH; Lu J; Bradshaw TD; Holmgren A
    FASEB J; 2008 Jun; 22(6):2072-83. PubMed ID: 18180330
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Noble metal targeting of thioredoxin reductase--covalent complexes with thioredoxin and thioredoxin-related protein of 14 kDa triggered by cisplatin.
    Prast-Nielsen S; Cebula M; Pader I; Arnér ES
    Free Radic Biol Med; 2010 Dec; 49(11):1765-78. PubMed ID: 20851179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New inhibitors of the thioredoxin-thioredoxin reductase system based on a naphthoquinone spiroketal natural product lead.
    Wipf P; Hopkins TD; Jung JK; Rodriguez S; Birmingham A; Southwick EC; Lazo JS; Powis G
    Bioorg Med Chem Lett; 2001 Oct; 11(19):2637-41. PubMed ID: 11551767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro and in vivo antitumor activities of three novel binuclear platinum(II) complexes with 4'-substituted-2,2':6',2″-terpyridine ligands.
    Qin QP; Wang ZF; Wang SL; Luo DM; Zou BQ; Yao PF; Tan MX; Liang H
    Eur J Med Chem; 2019 May; 170():195-202. PubMed ID: 30897397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of platinum and ruthenium bipyridyl complexes on porcine pancreatic phospholipase A2.
    Kamčeva T; Flemmig J; Damnjanović B; Arnhold J; Mijatović A; Petković M
    Metallomics; 2011 Oct; 3(10):1056-63. PubMed ID: 21909579
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and evaluation of 1,4-naphthoquinone ether derivatives as SmTGR inhibitors and new anti-schistosomal drugs.
    Johann L; Belorgey D; Huang HH; Day L; Chessé M; Becker K; Williams DL; Davioud-Charvet E
    FEBS J; 2015 Aug; 282(16):3199-217. PubMed ID: 26111549
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and characterization of platinum(II) oxadiazoline complexes and their in vitro antitumor activity in platinum-sensitive and -resistant cancer cell lines.
    Coley HM; Sarju J; Wagner G
    J Med Chem; 2008 Jan; 51(1):135-41. PubMed ID: 18072719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of cytotoxic cis- and trans-diammine monochlorido platinum(II) complexes on selenium-dependent redox enzymes and DNA.
    Lemmerhirt H; Behnisch S; Bodtke A; Lillig CH; Pazderova L; Kasparkova J; Brabec V; Bednarski PJ
    J Inorg Biochem; 2018 Jan; 178():94-105. PubMed ID: 29125948
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
    Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
    J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activity of platinum(II) intercalating agents against murine leukemia L1210.
    McFadyen WD; Wakelin LP; Roos IA; Leopold VA
    J Med Chem; 1985 Aug; 28(8):1113-6. PubMed ID: 4020833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Water-soluble organotellurium compounds inhibit thioredoxin reductase and the growth of human cancer cells.
    Engman L; Kandra T; Gallegos A; Williams R; Powis G
    Anticancer Drug Des; 2000 Oct; 15(5):323-30. PubMed ID: 11354308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anticancer and Antiangiogenic Iron(II) Complexes That Target Thioredoxin Reductase to Trigger Cancer Cell Apoptosis.
    Xie L; Luo Z; Zhao Z; Chen T
    J Med Chem; 2017 Jan; 60(1):202-214. PubMed ID: 28001402
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and antitumor activity of a series of [2-substituted-4,5-bis(aminomethyl)-1,3-dioxolane]platinum(II) complexes.
    Kim DK; Kim G; Gam J; Cho YB; Kim HT; Tai JH; Kim KH; Hong WS; Park JG
    J Med Chem; 1994 May; 37(10):1471-85. PubMed ID: 8182706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Degradation of bidentate-coordinated platinum(II)-based DNA intercalators by reduced L-glutathione.
    Kemp S; Wheate NJ; Pisani MJ; Aldrich-Wright JR
    J Med Chem; 2008 May; 51(9):2787-94. PubMed ID: 18412325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of thioredoxin reductase by a novel series of bis-1,2-benzisoselenazol-3(2H)-ones: Organoselenium compounds for cancer therapy.
    He J; Li D; Xiong K; Ge Y; Jin H; Zhang G; Hong M; Tian Y; Yin J; Zeng H
    Bioorg Med Chem; 2012 Jun; 20(12):3816-27. PubMed ID: 22579620
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells.
    Hyeraci M; Scalcon V; Folda A; Labella L; Marchetti F; Samaritani S; Rigobello MP; Dalla Via L
    ChemMedChem; 2021 Jun; 16(12):1956-1966. PubMed ID: 33751814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metal complexes of 3-(4-bromophenyl)-1-pyridin-2-ylprop-2-en-1-one thiosemicarbazone: cytotoxic activity and investigation on the mode of action of the gold(III) complex.
    Sâmia LB; Parrilha GL; Da Silva JG; Ramos JP; Souza-Fagundes EM; Castelli S; Vutey V; Desideri A; Beraldo H
    Biometals; 2016 Jun; 29(3):515-26. PubMed ID: 27091443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical, biochemical and pharmacological activity of the novel sterically hindered platinum co-ordination complex, cis-[amminedichloro(2-methylpyridine)] platinum(II) (AMD473).
    Holford J; Raynaud F; Murrer BA; Grimaldi K; Hartley JA; Abrams M; Kelland LR
    Anticancer Drug Des; 1998 Jan; 13(1):1-18. PubMed ID: 9474239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.